VEPKEA - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Image for trademark with serial number 97003517
Serial Number
97003517
Word Mark
VEPKEA
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2021-09-03
Filing Date
2021-08-31
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Statements
Goods and Services
Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations for the treatment of respiratory conditions, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations for treating immunodeficiency, namely, an immunology antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations for treating hereditary angioedema, namely, antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders, namely, a haematology antibody for the treatment of Hereditary Angioedema, HAE
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-10-14
Primary Code
005
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Scott D. Woldow
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
EUFalse
Trademark Events
Event DateEvent Description
2021-09-03NEW APPLICATION ENTERED IN TRAM
2021-10-14NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2021-09-22TEAS VOLUNTARY AMENDMENT RECEIVED
2021-10-18ASSIGNED TO LIE
2021-10-20PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED